Table 3 Characteristics of participants at excess risk of lung cancer
Clinical and demographic features of participants at excess risk of lung cancer n = 159 |  |
Current age: median (range) | 55 (29–80) |
Gender | Female: 96 (60.3%) |
Male: 64 (39.7%) | |
Ethnicity | White British: 147 (92%) |
Othera: 12 (8%) | |
Level of education (n = 156) | Education below university level: 86 (54.7%) |
University educated: 57 (37%) | |
No educational qualifications: 13 (8.3%) | |
Employment (n = 158) | Full or part time employed (or in full time education/training): 101 (64%) |
Retired: 40 (25.3%) | |
Other: 17 (10.7%) | |
HL classification | Classical HL: 150 (94%) |
Nodular lymphocyte predominant HL: 9 (6%) | |
Years since diagnosis: median (range) | 24 (6–48) |
Time since last treatment: median (range) | 23 (6–44) |
Sites of radiation (lung and non-lung) n = 144 | Mediastinal ± other area: 95 (66%) |
Mantle field ± other area: 28 (19%) | |
Other area: 21 (15%) | |
Chemotherapy regimensb (n = 150) | ChlVPP/EVA only: 46 (31%) |
ABVD only: 43 (29%) | |
MVPP only: 19 (13%) | |
Multiple chemotherapy regimens: 32 (21%) (of whom 17 underwent stem cell transplant and of whom 28 received procarbazine or mechlorethamine) | |
VAPEC-B only: 10 (6%) | |
Cause of excess lung cancer risk by treatment modality | Radiation to lung and alkylating agent: 78 (49%) |
Radiation to lung only: 66 (41.5%) | |
Alkylating agent only: 15 (9.5%) | |
Smoking history (n = 157) | Never smokers: 96 (62%) |
Former smokers: 49 (31%) | |
Current smokers: 12 (7%) | |
Family history of lung cancer (n = 159) | In parents or siblings: 12 (8%) |
Another family member: 20 (13%) | |
Self-rated health (n = 157) | Excellent/very good: 46 (29.3%) |
Good/fair: 97 (61.8%) | |
Poor/very poor: 14 (8.9%) | |
Revised Life-Orientation Test scores (possible range 0–24): median (range) | 15 (0–23) |